Ovarian Cancer Treatments – TomoTherapy®
Learn More About Ovarian Cancer TomoTherapy: Chat with Us | Email Us
TomoTherapy® for Ovarian Cancer
TomoTherapy® Highly Integrated Adaptive Radiotherapy (HI-ART), an innovative new type of radiotherapy, is another ovarian cancer treatment option offered at Cancer Treatment Centers of America (CTCA).
TomoTherapy® HI-ART consists of a sophisticated hardware and software system that combines several leading ovarian cancer treatment technologies into a single machine. This integrated system combines an advanced form of Intensity Modulated Radiation Therapy (IMRT) with capabilities for CT scanning, as well as state-of-the-art tools to help CTCA oncologists plan and deliver radiotherapy treatments.
The following are some major benefits of TomoTherapy® HI-ART for ovarian cancer treatment:
- Smaller and more precise radiation beams make hard-to-reach tumors easier to isolate
- Built-in CT scanning helps target treatment by confirming the exact shape and position of ovarian cancer tumors seconds before your treatment begins
- Healthy surrounding tissue is better protected from excess radiation exposure, often dramatically reducing side effects
TomoTherapy® HI-ART is a promising new method of ovarian cancer treatment for patients who have reached the maximum tolerance dose of traditional radiation, or whose tumor is in a hard-to-reach area.
While traditional methods of radiation therapy are only able to project radiation in a few directions, TomoTherapy® HI-ART delivers precise and powerful doses of radiation therapy from a full 360-degrees. This enhanced flexibility allows CTCA radiation oncologists to better target ovarian cancer tumors located in especially sensitive or hard-to-reach areas.
TomoTherapy® HI-ART also uses an on-board CT scanner to determine if the tumor has shifted or changed shape since your last treatment. This feature helps prevent radiation beams from targeting nearby healthy tissue and organs.
To learn if TomoTherapy® HI-ART is an appropriate ovarian cancer treatment option for you, call us anytime at 1-800-615-3055 or chat online with a CTCA Oncology Information Specialist today.
Next Topic: Chemotherapy for Ovarian Cancer